BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MicroConstants China's New Facility Passes OECD GLP Compliance Inspection


8/28/2012 10:11:19 AM

BEIJING, CHINA, August 27, 2012 - MicroConstants China Inc., a Contract Research Organization (CRO) conducting preclinical PK studies and providing full-service early stage clinical trial management in China, has received a renewed Endorsement of Compliance with the OECD Principles of Good Laboratory Practice (GLP) at its newly established facility in Beijing. The Endorsement was initially awarded in May 2011 following an inspection at MicroConstants China’s previous location.

In February, MicroConstants China relocated their laboratory to a new 8,000 square foot facility in the Huilongsen International Science & Technology Park in the Beijing Development Area (BDA) in southeast Beijing. After months of internal testing and qualification of all equipment, the new facility was visited by the Health Care Inspectorate, Ministry of Health, Welfare and Sport of Netherlands for a GLP compliance reassessment. Following a week long inspection in June, the Inspectorate confirmed the new facility is compliant with the OECD Principles of GLP in the areas of analytical chemistry and pharmacokinetic studies and the Endorsement of Compliance was renewed.

"The continued OECD GLP Endorsement, along with the CNAS accreditation received in 2010, exemplifies our pursuit of conducting high quality contract research services to meet global regulatory requirements,” said Dr. Q. David Yang, CEO of MicroConstants China. "We will continue to expand our scope of services and capabilities to meet our clients' demands."

“This is truly a historical moment for China and MicroConstants,” said Dr. Gilbert Lam, founder of MicroConstants China and president of MicroConstants, Inc. in San Diego, California. “It reflects our commitment to be the leader in GLP compliance.”

About MicroConstants China Inc.

MicroConstants China Inc. is a Contract Research Organization (CRO) that was established in 2007 by the founder and president of MicroConstants, Inc., a bioanalytical and DMPK specialty CRO in San Diego, California with over a decade of GLP compliance history. Located in Beijing, MicroConstants China provides preclinical and clinical pharmacokinetic analysis, analytical services, and early stage clinical trial management services, including clinical site qualification, trial monitoring, data management, biostatistics, and clinical summary reports to pharmaceutical and biotech companies worldwide. Additionally, the CRO offers QA audit and drug development project management services for preclinical toxicology and pharmacology studies in China. Its bioanalytical laboratory is fully GLP-compliant with USFDA, OECD, Japan MHLW and China SFDA guidelines. For more information about MicroConstants China and the contract research services they provide, please visit http://www.microconstants.com.cn.

For more information, contact:

Jessica Hou

MicroConstants China Inc.

jhou@microconstants.com

Tel: +86 133 1111-8640



Read at BioSpace.com
Read at ChinaBio Today

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES